特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
表紙
市場調査レポート
商品コード
955722

新型コロナウイルス感染症診断の世界市場:検査タイプ別、ユーザー別、検査時間別、エンドユーザー別、地域別の競合情勢、予測、機会

Global Coronavirus Diagnostics Market By Type of Test, By User, By Full Test Time, By End User, By Region, Competition, Forecast & Opportunities, 2025

出版日: | 発行: TechSci Research | ページ情報: 英文 135 Pages | 納期: お問合せ

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=106.56円

こちらのレポートには、数時間(ご購入金額の10%)分のアナリストへの質問/追加調査サービスが含まれております。

新型コロナウイルス感染症診断の世界市場:検査タイプ別、ユーザー別、検査時間別、エンドユーザー別、地域別の競合情勢、予測、機会
出版日: 2020年09月01日
発行: TechSci Research
ページ情報: 英文 135 Pages
納期: お問合せ
担当者のコメント
COVID19感染症診断における各国別の市場動向を2025年度まで分析した調査レポートです。検査時間や検査種類別、ユーザー種類別、企業別など、様々な切り口において予測値はまとめられております。まずはサンプルページを送付させていただきますので、お知らせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

現在パンデミックが進行中の新型コロナウイルス感染症(COVID-19)は、SARS-COV-2が原因で発生し、一般に動物からヒトへ、ヒトからヒトへと広がります。病気は通常、感染した人の唾液の飛沫や感染した人が咳やくしゃみをする際に飛び散る鼻汁などから広がります。最初の症例は2019年12月に中国の武漢で報告されており、その後世界のさまざまな地域に拡大して数百万人の感染者を出しています。 2020年4月9日の時点で、世界全体のコロナウイルスの感染者数は150万人を超えており、そのうち約33万人が回復、8万8千人以上が亡くなっています。こうした世界規模のパンデミックを背景に、世界のコロナウイルス診断市場は、2015年から2025年まで12%を超えるCAGRで成長すると予想されています。

当レポートは、世界のコロナウイルス診断市場を調査したもので、顧客の声、世界と各地域市場の展望、市場の力学、主なトレンド、競合情勢と企業プロファイルなどの情報を提供しています。

目次

第1章 製品の概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

  • ブランド認知度
  • 製品の認知度
  • 顧客満足度分析
  • 価格分析
  • 未対応のニーズ/課題

第5章 市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 検査タイプ別(分子、血清)
    • ユーザー別(単一、複数)
    • 検査時間別(60分未満、1時間~12時間、13時間~24時間、1日以上)
    • エンドユーザー別(病院、公衆衛生検査室、民間または営利企業の検査室、医院の検査室、その他)
    • 企業別(2020)
    • 地域別
  • 製品市場マップ

第6章 欧州市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 検査タイプ別
    • ユーザー別
    • エンドユーザー別
    • 国別
  • 国別分析
    • ロシア
    • イタリア
    • スペイン
    • ドイツ
    • フランス
    • 英国

第7章 北米市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 検査タイプ別
    • ユーザー別
    • エンドユーザー別
    • 国別
  • 国別分析
    • 米国
    • カナダ
    • メキシコ

第8章 アジア太平洋市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 検査タイプ別
    • ユーザー別
    • エンドユーザー別
    • 国別
  • 国別分析
    • 中国
    • 韓国
    • オーストラリア
    • インド
    • 日本
    • タイ
    • シンガポール

第9章 中東・アフリカ

  • 市場規模と予測
  • 市場シェアと予測
    • 検査タイプ別
    • ユーザー別
    • エンドユーザー別
    • 国別
  • 国別分析
    • イラン
    • UAE
    • サウジアラビア
    • 南アフリカ

第10章 南米市場の展望

  • 市場規模と予測
  • 市場シェアと予測
    • 検査タイプ別
    • ユーザー別
    • エンドユーザー別
    • 国別
  • 国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向

第13章 競合情勢

  • Abbott Laboratories
  • Altona Diagnostics GmbH
  • BioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F.Hoffmann-La Roche Ltd
  • GSK Biologicals SA
  • Mylab Discovery Solutions Pvt. Ltd.
  • Seegene Inc.
  • Siemens AG
  • Thermo Fisher Scientific Inc.

第14章 戦略的提言

図表

List of Figures

  • Figure 1: Global Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 2: Global Healthcare Spending, By Region, By Value, 2019 (USD Billion)
  • Figure 3: Global Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 4: Global Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 5: Global Coronavirus Diagnostics Market Share, By Full Test Time, By Value, 2015-2025F
  • Figure 6: Global Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 7: Global Coronavirus Diagnostics Market Share, By Region, By Value, 2015-2025F
  • Figure 8: Global Coronavirus Diagnostics Market Share, By Company, By Value, 2020
  • Figure 9: Global Coronavirus Diagnostics Market Size (USD Million) & Growth Rate (%), By Type of Test, 2015-2025F
  • Figure 10: Global Coronavirus Diagnostics Market Size (USD Million) & Growth Rate (%), By User, 2015-2025F
  • Figure 11: Europe Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 12: Europe Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 13: Europe Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 14: Europe Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 15: Europe Coronavirus Diagnostics Market Share, By Country, By Value, 2015-2025F
  • Figure 16: Russia Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 17: Russia Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 18: Russia Consolidated Budget Expenditure on Health Share to GDP, (%) 2015-2019
  • Figure 19: Russia Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 20: Russia Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 21: Germany Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 22: Germany Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 23: Germany Coronavirus Reported Cases, By Region, As of 21st April 2020 (In Nos)
  • Figure 24: Germany Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 25: Germany Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 26: United Kingdom Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 27: United Kingdom Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 28: United Kingdom Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 29: United Kingdom Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 30: Italy Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 31: Italy Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 32: Italy Covid-19 Cumulative Statistics, By Value, Till 13 May 2020
  • Figure 33: Italy Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 34: Italy Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 35: Spain Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 36: Spain Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 37: Spain Covid-19 Cumulative Statistics, By Value, Till 13 May 2020
  • Figure 38: Spain Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 39: Spain Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 40: France Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 41: France Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 42: France Number of Covid-19 Cases, By Value, Feb 2020 - May 2020
  • Figure 43: France Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 44: France Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 45: North America Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 46: North America Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 47: North America Health Spending Share, By Value, 2019
  • Figure 48: North America Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 49: North America Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 50: North America Coronavirus Diagnostics Market Share, By Country, By Value, 2015-2025F
  • Figure 51: United States Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 52: United States Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 53: United States Healthcare Spending, By Value, 2018 -2021F (USD Per Capita)
  • Figure 54: United States Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 55: United States Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 56: Canada Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 57: Canada Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 58: Canada Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 59: Canada Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 60: Mexico Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 61: Mexico Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 62: Mexico Pharmaceutical Products Market Size, By Value, 2015 - 2025F (USD Billion)
  • Figure 63: Mexico Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 64: Mexico Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 65: Asia-Pacific Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 66: Asia-Pacific Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 67: Asia-Pacific Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 68: Asia-Pacific Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 69: Asia-Pacific Coronavirus Diagnostics Market Share, By Country, By Value, 2015-2025F
  • Figure 70: China Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 71: China Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 72: China Covid-19 Cumulative Statistics, By Value, Till 14th May 2020
  • Figure 73: China Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 74: China Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 75: India Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 76: India Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 77: India Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 78: India Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 79: South Korea Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 80: South Korea Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 81: South Korea Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 82: South Korea Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 83: Australia Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 84: Australia Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 85: Australia Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 86: Australia Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 87: Japan Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 88: Japan Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 89: Japan Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 90: Japan Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 91: Japan Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 92: Thailand Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 93: Thailand Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 94: Thailand Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 95: Thailand Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 96: Singapore Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 97: Singapore Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 98: Singapore Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 99: Singapore Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 100: Middle East & Africa Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 101: Middle East & Africa Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 102: Middle East & Africa Pharmaceutical Market Size, By Value, 2019 (USD Billion)
  • Figure 103: Middle East & Africa Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 104: Middle East & Africa Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 105: Middle East & Africa Coronavirus Diagnostics Market Share, By Country, By Value, 2015-2025F
  • Figure 106: Iran Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 107: Iran Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 108: Iran Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 109: Iran Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 110: UAE Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 111: UAE Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 112: UAE Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 113: UAE Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 114: Saudi Arabia Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 115: Saudi Arabia Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 116: Saudi Arabia Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 117: Saudi Arabia Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 118: South Africa Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 119: South Africa Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 120: South Africa Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 121: South Africa Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 122: South America Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 123: South America Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 124: South America Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 125: South America Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 126: South America Coronavirus Diagnostics Market Share, By Country, By Value, 2015-2025F
  • Figure 127: Brazil Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 128: Brazil Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 129: Brazil Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 130: Brazil Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 131: Argentina Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 132: Argentina Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 133: Argentina Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 134: Argentina Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
  • Figure 135: Colombia Coronavirus Diagnostics Market Size, By Value (USD Million), 2015-2025F
  • Figure 136: Colombia Coronavirus Diagnostics Market Share, By Type of Test, By Value, 2015-2025F
  • Figure 137: Colombia Coronavirus Diagnostics Market Share, By User, By Value, 2015-2025F
  • Figure 138: Colombia Coronavirus Diagnostics Market Share, By End User, By Value, 2015-2025F
目次
Product Code: 4574

Title:
Global Coronavirus Diagnostics Market By Type of Test (Molecular v/s Serology), By User (Single v/s Multiple), By Full Test Time (Less Than 60 Minutes, 1 Hour - 12 Hours, 13 Hours - 24 Hours, More Than 1 Day), By End User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Others), By Region, Competition, Forecast & Opportunities, 2025.

The ongoing pandemic novel coronavirus disease (COVID-19) is caused due to SARS-COV-2 and generally spreads from animals to humans and then from humans to humans. The disease usually spreads from saliva droplets of the infected person or the nose discharges of the infected person when they cough or sneeze. First case of the disease was reported in December 2019 in Wuhan, China and since then, it has spread to various parts of the world infecting millions. As of 9th April 2020, the total number of coronavirus cases crossed 1.5 million, globally, of which around 330,000 had recovered and over 88,000 people had died.

Global coronavirus diagnostics market is expected to grow at a CAGR of more than 12% during 2015-2025. The global coronavirus diagnostics market is driven by surging incidences of this disease across different parts of the globe. The market is segmented based on type of test, user, full test time, end user, company and region. Based on type of test, market can be bifurcated into molecular and serological tests. The molecular type of test segment is expected to dominate the market during forecast period. In this testing procedure, a sample from the back of the throat is taken and sent for testing. The sample undergoes a PCR test to find out the presence of virus genetic material. The PCR confirms the diagnosis of COVID-19 if it finds two genes of SARS-COV-2 virus.

Europe and North America are expected to witness significant growth during the forecast period owing to the presence of many research laboratories and pharmaceutical & biotechnology companies across the regions. Major players operating in the coronavirus diagnostics market include F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Siemens AG, Thermo Fisher Scientific Inc., Mylab Discovery Solutions Pvt. Ltd., Bio-Rad Laboratories, Inc., BioMerieux SA, GSK Biologicals SA, Altona Diagnostics GmbH, Seegene Inc., and others.

Years considered for this report:

  • Historical Year: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020E
  • Forecast Period: 2021-2025

Objective of the Study:

  • To estimate and forecast the market size of global coronavirus diagnostics market from 2015 to 2025F.
  • To classify and forecast global coronavirus diagnostics market based on type of test, user, full test time, end user, company and regional distribution.
  • To identify dominant regions and segments in the global coronavirus diagnostics market.
  • To identify drivers and challenges for global coronavirus diagnostics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global coronavirus diagnostics market.
  • To identify and analyze the profile of leading players operating in global coronavirus diagnostics market.
  • To identify key sustainable strategies adopted by market players in global coronavirus diagnostics market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of diagnostic players operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the market players which could not be identified due to the limitations of secondary research.

TechSci Research calculated the market size of global coronavirus diagnostics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Coronavirus diagnostic kits manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to coronavirus diagnostics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders, besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global coronavirus diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Type of Test:

  • Molecular
  • Serology

Market, By User:

  • Single
  • Multiple

Market, By Full Test Time:

  • Less Than 60 Minutes
  • 1 Hour - 12 Hours
  • 13 Hours - 24Hours
  • More Than 1 Day

Market, By End User:

  • Hospitals
  • Public Health Labs
  • Private or Commercial Labs
  • Physician Labs
  • Others

Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Russia
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
    • Singapore
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Iran
  • South America
    • Brazil
    • Argentina
    • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global coronavirus diagnostics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

  • 4.1. Brand Awareness (Aided/Unaided)
  • 4.2. Product Awareness
  • 4.3. Customer Satisfaction Analysis
  • 4.4. Pricing Analysis
  • 4.5. Unmet Needs/Challenges

5. Global Coronavirus Diagnostics Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Type of Test (Molecular v/s Serology)
    • 5.2.2. By User (Single v/s Multiple)
    • 5.2.3. By Full Test Time (Less Than 60 Minutes, 1 Hours to 12 Hours, 13 Hours-24Hours, More Than 1 Days)
    • 5.2.4. By End User (Hospitals, Public Health Labs, Private or Commercial Labs, Physician Labs, Others)
    • 5.2.5. By Company (2020)
    • 5.2.6. By Region
  • 5.3. Product Market Map

6. Europe Coronavirus Diagnostics Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Type of Test
    • 6.2.2. By User
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. Europe: Country Analysis
    • 6.3.1. Russia Coronavirus Diagnostics Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Type of Test
        • 6.3.1.2.2. By User
        • 6.3.1.2.3. By End User
    • 6.3.2. Italy Coronavirus Diagnostics Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Type of Test
        • 6.3.2.2.2. By User
        • 6.3.2.2.3. By End User
    • 6.3.3. Spain Coronavirus Diagnostics Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Type of Test
        • 6.3.3.2.2. By User
        • 6.3.3.2.3. By End User
    • 6.3.4. Germany Coronavirus Diagnostics Market Outlook
      • 6.3.4.1. Market Size & Forecast
        • 6.3.4.1.1. By Value
      • 6.3.4.2. Market Share & Forecast
        • 6.3.4.2.1. By Type of Test
        • 6.3.4.2.2. By User
        • 6.3.4.2.3. By End User
    • 6.3.5. France Coronavirus Diagnostics Market Outlook
      • 6.3.5.1. Market Size & Forecast
        • 6.3.5.1.1. By Value
      • 6.3.5.2. Market Share & Forecast
        • 6.3.5.2.1. By Type of Test
        • 6.3.5.2.2. By User
        • 6.3.5.2.3. By End User
    • 6.3.6. United Kingdom Coronavirus Diagnostics Market Outlook
      • 6.3.6.1. Market Size & Forecast
        • 6.3.6.1.1. By Value
      • 6.3.6.2. Market Share & Forecast
        • 6.3.6.2.1. By Type of Test
        • 6.3.6.2.2. By User
        • 6.3.6.2.3. By End User

7. North America Coronavirus Diagnostics Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Type of Test
    • 7.2.2. By User
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. North America: Country Analysis
    • 7.3.1. United States Coronavirus Diagnostics Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Type of Test
        • 7.3.1.2.2. By User
        • 7.3.1.2.3. By End User
    • 7.3.2. Canada Coronavirus Diagnostics Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Type of Test
        • 7.3.2.2.2. By User
        • 7.3.2.2.3. By End User
    • 7.3.3. Mexico Coronavirus Diagnostics Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Type of Test
        • 7.3.3.2.2. By User
        • 7.3.3.2.3. By End User
        • 7.3.3.2.4.

8. Asia-Pacific Coronavirus Diagnostics Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Type of Test
    • 8.2.2. By User
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Coronavirus Diagnostics Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Type of Test
        • 8.3.1.2.2. By User
        • 8.3.1.2.3. By End User
    • 8.3.2. South Korea Coronavirus Diagnostics Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Type of Test
        • 8.3.2.2.2. By User
        • 8.3.2.2.3. By End User
    • 8.3.3. Australia Coronavirus Diagnostics Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Type of Test
        • 8.3.3.2.2. By User
        • 8.3.3.2.3. By End User
    • 8.3.4. India Coronavirus Diagnostics Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Type of Test
        • 8.3.4.2.2. By User
        • 8.3.4.2.3. By End User
    • 8.3.5. Japan Coronavirus Diagnostics Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Type of Test
        • 8.3.5.2.2. By User
        • 8.3.5.2.3. By End User
    • 8.3.6. Thailand Coronavirus Diagnostics Market Outlook
      • 8.3.6.1. Market Size & Forecast
        • 8.3.6.1.1. By Value
      • 8.3.6.2. Market Share & Forecast
        • 8.3.6.2.1. By Type of Test
        • 8.3.6.2.2. By User
        • 8.3.6.2.3. By End User
    • 8.3.7. Singapore Coronavirus Diagnostics Market Outlook
      • 8.3.7.1. Market Size & Forecast
        • 8.3.7.1.1. By Value
      • 8.3.7.2. Market Share & Forecast
        • 8.3.7.2.1. By Type of Test
        • 8.3.7.2.2. By User
        • 8.3.7.2.3. By End User

9. Middle East and Africa Coronavirus Diagnostics Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Type of Test
    • 9.2.2. By User
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. MEA: Country Analysis
    • 9.3.1. Iran Coronavirus Diagnostics Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Type of Test
        • 9.3.1.2.2. By User
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Coronavirus Diagnostics Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Type of Test
        • 9.3.2.2.2. By User
        • 9.3.2.2.3. By End User
    • 9.3.3. Saudi Arabia Coronavirus Diagnostics Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Type of Test
        • 9.3.3.2.2. By User
        • 9.3.3.2.3. By End User
    • 9.3.4. South Africa Coronavirus Diagnostics Market Outlook
      • 9.3.4.1. Market Size & Forecast
        • 9.3.4.1.1. By Value
      • 9.3.4.2. Market Share & Forecast
        • 9.3.4.2.1. By Type of Test
        • 9.3.4.2.2. By User
        • 9.3.4.2.3. By End User

10. South America Coronavirus Diagnostics Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Type of Test
    • 10.2.2. By User
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Coronavirus Diagnostics Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Type of Test
        • 10.3.1.2.2. By User
        • 10.3.1.2.3. By End User
    • 10.3.2. Argentina Coronavirus Diagnostics Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Type of Test
        • 10.3.2.2.2. By User
        • 10.3.2.2.3. By End User
    • 10.3.3. Colombia Coronavirus Diagnostics Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Type of Test
        • 10.3.3.2.2. By User
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Abbott Laboratories
  • 13.2. Altona Diagnostics GmbH
  • 13.3. BioMerieux SA
  • 13.4. Bio-Rad Laboratories, Inc.
  • 13.5. Danaher Corporation
  • 13.6. F.Hoffmann-La Roche Ltd
  • 13.7. GSK Biologicals SA
  • 13.8. Mylab Discovery Solutions Pvt. Ltd.
  • 13.9. Seegene Inc.
  • 13.10. Siemens AG
  • 13.11. Thermo Fisher Scientific Inc.

14. Strategic Recommendations

株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.